Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Cell Physiol ; 298(2): C313-23, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19889960

ABSTRACT

Hyperglycemia-associated glucotoxicity induces beta-cell apoptosis but the underlying mechanisms are unknown. Interestingly, prolonged exposure to high glucose upregulates the expression and function of the renin-angiotensin system (RAS). We hypothesize that the voltage-gated outward potassium (K(v)) current, which governs beta-cell membrane potential and insulin secretion, has a role in glucotoxicity. In this study, we investigated the effects of prolonged exposure to high glucose on mouse pancreatic beta-cells and concurrent effects on the RAS by examining changes in expression of angiotensin II (ANG II) receptors and changes in the expression and activity of K(v) channels. beta-Cells were incubated in high glucose medium for 1-7 days and then were examined with electrophysiological and molecular biology techniques. Prolonged exposure to high glucose produced a marked increase in beta-cell primary K(v) channel subunit, K(v)2.1, expression and K(v) current amplitude. Enhanced expression of ANG II type 1 receptor (AT(1)R) was also observed under high glucose conditions, whereas blockade of AT(1)R by losartan did not alter K(v) channel expression. External application of ANG II reduced K(v) current amplitude under normal, but not high, glucose conditions. The effect of ANG II on K(v) channel gating was abolished by ANG II type 2 receptor (AT(2)R) antagonism. These data suggest that hyperglycemia alters beta-cell function through modification of the K(v) channel which may be associated with the RAS.


Subject(s)
Angiotensin II/metabolism , Glucose/metabolism , Insulin-Secreting Cells/metabolism , Potassium/metabolism , Receptor, Angiotensin, Type 2/metabolism , Renin-Angiotensin System , Shab Potassium Channels/metabolism , Signal Transduction , Angiotensin II Type 1 Receptor Blockers/pharmacology , Angiotensin II Type 2 Receptor Blockers , Animals , Cells, Cultured , Imidazoles/pharmacology , Insulin/metabolism , Insulin-Secreting Cells/drug effects , Ion Channel Gating , Losartan/pharmacology , Male , Membrane Potentials , Mice , Mice, Inbred C57BL , Pyridines/pharmacology , RNA, Messenger/metabolism , Receptor, Angiotensin, Type 1/drug effects , Receptor, Angiotensin, Type 1/metabolism , Receptor, Angiotensin, Type 2/genetics , Renin-Angiotensin System/drug effects , Shab Potassium Channels/genetics , Signal Transduction/drug effects , Time Factors
2.
Eur J Pharmacol ; 546(1-3): 134-41, 2006 Sep 28.
Article in English | MEDLINE | ID: mdl-16904102

ABSTRACT

In this study, we compared the endothelium-dependent and -independent relaxation of the isolated thoracic aorta of control (+db/+m) and diabetic (+db/+db) (C57BL/KsJ) mice. The gene expression (mRNA and protein) level of the muscarinic M(3) receptors, endothelial nitric oxide synthase (eNOS) and caveolin-1 of the aorta was also evaluated. Acetylcholine caused a concentration-dependent, N(G)-nitro-L-arginine methyl-ester (20 microM)-sensitive relaxation, with approximately 100% relaxation at 10 microM, in +db/+m mice. In +db/+db mice, the acetylcholine-induced relaxation was significantly smaller (maximum relaxation: approximately 80%). The sodium nitroprusside-mediated relaxation was slightly diminished in +db/+db mice, compared to +db/+m mice. However, there was no significant difference in the isoprenaline- and cromakalim-induced relaxation observed in both species. The mRNA and protein expression levels of caveolin-1 were significantly higher in the aorta of +db/+db mice. In contrast, there was no difference in the mRNA and protein expression levels of eNOS and muscarinic M(3) receptors between these mice. Our results demonstrate that the impairment of the acetylcholine-induced, endothelium-dependent aortic relaxation observed in +db/+db mice was probably associated with an enhanced expression of caveolin-1 mRNA and protein.


Subject(s)
Aorta, Thoracic/physiopathology , Caveolin 1/analysis , Diabetes Mellitus, Type 2/physiopathology , Vasodilation , Acetylcholine/pharmacology , Animals , Aorta, Thoracic/chemistry , Aorta, Thoracic/drug effects , Blood Glucose/metabolism , Blotting, Western , Cromakalim/pharmacology , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/metabolism , Dose-Response Relationship, Drug , Endothelium, Vascular/physiopathology , Enzyme Inhibitors/pharmacology , Female , Insulin/blood , Isoproterenol/pharmacology , Mice , Mice, Inbred C57BL , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase Type II/analysis , Nitric Oxide Synthase Type III , Nitroprusside/pharmacology , RNA, Messenger/analysis , Receptor, Muscarinic M3/analysis , Vasodilation/drug effects , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...